Viewpoint Medtech 2024: Great response and valuable insights into the future of medical technology

This year's Viewpoint Medtech took place on 18 November 2024 at the premises of ERBE Elektromedizin GmbH in Rangendingen. This series of events is an interactive forum that brings together experts and specialists from the medical technology industry. Organised by BioRegio STERN Management GmbH and Medical Valley Hechingen e. V., the event attracted around 120 participants in a relaxed atmosphere - a complete success.

Under the motto “Only those who participate have a voice,” the event provided an in-depth look at the current challenges and opportunities facing the industry. Highlights included the presentation of the Roland Berger Hospital Study 2024: No Future Without Mergers, which explored strategies for helping Germany's hospitals navigate their ongoing crisis. Additionally, SPECTARIS delivered an insightful presentation of the economic landscape of the German medical technology sector, a highly regulated high-tech industry.

The presentation by ECONUM highlighted the potential of artificial intelligence (AI) in medical technology, providing practical application examples and exploring the pivotal question: “Hype or game changer?”

Christian O. Erbe, Managing Director of Erbe Elektromedizin GmbH, Dr Heiko Zimmermann and Dr Steffen Hüttner gave opening remarks. The discussion, in which renowned experts such as Dr Peter Magunia (Roland Berger), Marcus Kuhlmann (SPECTARIS), Dr Oliver Müller (ECONUM) and Thomas Radtke (Cardiobridge GmbH) took part, provided in-depth insights and led to lively discussions among the participants.

The event provided an excellent platform for networking and a thorough analysis of the economic framework and potential of Germany's medical technology sector in the context of global competition. It was a successful meeting that also paved the way for promising future opportunities.

Info flyer Viewpoint Medtech 2024

Cover Standpunkt Medtech 2024 Front

You can read the details of the event and the agenda here (in german).

Source:
BioRegio STERN Management GmbH